EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Clinical and Genetic Characterization of a Novel RYR1 Variant (p.Gln474His) in Malignant Hyperthermia Susceptibility

Erin Tracy iD, Katelyn Mistretta, Peter Bedocs iD, Robert Vietor iD, Alakesh Bera iD

Genes · 2025

DOI: 10.3390/genes17010013 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Erin Tracy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, US…. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Malignant Hyperthermia, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense/USUHS, Department of the Navy (DoW) Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Malignant hyperthermia (MH) is a life-threatening pharmacogenetic disorder of skeletal muscle calcium regulation and commonly associated with pathogenic variants in the RYR1 gene. Interpretation of rare RYR1 variants remains challenging, particularly when classified as variants of uncertain significance (VUS). This study describes the clinical, functional, and genetic evaluation of a patient with suspected MH susceptibility carrying a rare RYR1 mutation.

Methods

We report a retrospective case evaluation of a 32-year-old female referred for MH assessment following a prior peri-operative hypermetabolic event. Clinical records were reviewed, and MH susceptibility was assessed using the caffeine–halothane contracture test (CHCT). Genetic testing was performed using a targeted MH susceptibility gene panel, including RYR1, CACNA1S, and STAC3. Variant classification was conducted following American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines.

Results

The patient demonstrated a positive CHCT, consistent with MH susceptibility. Genetic analysis identified a rare heterozygous RYR1 missense variant. No pathogenic or likely pathogenic variants were detected in CACNA1S or STAC3. Based on ACMG/AMP criteria, the RYR1 p.Gln474His variant is currently classified as a VUS. However, its localization within the N-terminal regulatory region of RyR1 and concordance with abnormal CHCT findings provide supportive functional context.

Conclusions

This case underscores the importance of integrating clinical history, functional contracture testing, and genetic data in the evaluation of MH susceptibility. While functional findings may support biological plausibility, definitive pathogenic classification of rare RYR1 variants requires additional segregation data or mechanistic studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ryanodine Receptor Calcium Release ChannelMalignant HyperthermiaGenetic Predisposition to DiseaseHumansFemaleAdultMutation, MissenseCaffeineRetrospective StudiesCalcium Channels, L-Type

Stichwörter der Autor:innen

RYR1 variantand caffeine-halothane contracture test (CHCT)malignant hyperthermia

Substanzen

Ryanodine Receptor Calcium Release ChannelRYR1 protein, humanCaffeineCACNA1S protein, humanCalcium Channels, L-Type

Autor:innen und Institutionen

  • Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA.

ORCID-Profile: Erin Tracy, Peter Bedocs, Robert Vietor, Alakesh Bera

Förderung

  • United States Department of Defense/USUHS
  • Department of the Navy (DoW) Grant

Zitieren

APA

Tracy, E., Mistretta, K., Bedocs, P., Vietor, R., & Bera, A. (2025). Clinical and Genetic Characterization of a Novel RYR1 Variant (p.Gln474His) in Malignant Hyperthermia Susceptibility. Genes. https://doi.org/10.3390/genes17010013

Vancouver

Tracy E, Mistretta K, Bedocs P, Vietor R, Bera A. Clinical and Genetic Characterization of a Novel RYR1 Variant (p.Gln474His) in Malignant Hyperthermia Susceptibility. Genes. 2025. doi:10.3390/genes17010013

BibTeX
@article{Tracy2025,
  author = {Tracy, Erin and Mistretta, Katelyn and Bedocs, Peter and Vietor, Robert and Bera, Alakesh},
  title = {Clinical and Genetic Characterization of a Novel RYR1 Variant (p.Gln474His) in Malignant Hyperthermia Susceptibility},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes17010013}
}
Kostenlos starten →